You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆匯港股聚焦(9.16)︱君實生物獲微境生物四款藥物全球銷售權 ;中國有贊擬1.6億美元認購Qima股份
格隆匯 09-16 23:02

新股上市】

華住集團-S(01179.HK)發售價確定為每股297港元 募集資金60.65億港元

【財務數據】

堡獅龍國際(00592.HK)年度虧損擴大至3.68億港元

【業績預告】

HSSP INTL(03626.HK)料年度盈轉虧至1000萬港元

【增減持】

中國外運(00598.HK):中國外運長航已累計增持1062萬股公司A股

浙商銀行(02016.HK):部分高管已增持298.61萬股A股,增持計劃完成

漢港控股(01663.HK)獲主要股東汪林冰增持36.8萬股

【併購出售】

中國有贊(08083.HK)擬1.6億美元認購Qima股份 持股升至51.9%

黛麗斯國際(00333.HK)擬2800萬港元出售香港九龍弼街物業

北京燃氣藍天(06828.HK):北京北藍擬向崑崙實華購買液化天然氣

思城控股(01486.HK)擬收購邁達投資管理60%股權,試水金融投資業務

國投集團控股(01386.HK)洽購明大智能設備科技的最低51%註冊股本

賢能集團(01730.HK)擬收購Balestier物業用作共居空間經營

【增發供股

中國海洋發展(08047.HK)擬向江浩邦折讓19%配股 淨籌970萬港元

【要約私有化】

浦江國際(02060.HK)建議私有化奧盛創新

【重大事項】

君實生物(01877.HK)與微境生物簽署技術轉讓及合作協議

中國生物科技服務(08037.HK)附屬為香港市民提供超160萬次Covid-19核酸檢測服務

雅天妮集團(00789.HK)擬於中國開展大健康業務

駿傑集團控股(08188.HK)獲授一份建造合約 涉資約9210萬港元

薈萃國際控股(08041.HK)與FAL訂立備忘錄,擬合作創立線上黃金交易平台

【基金理財】

順誠(00531.HK)7004萬美元出售基金投資權益

回購註銷】

中國旺旺(00151.HK)9月16日耗資5385.35萬港元回購1000萬股

石四藥集團(02005.HK)9月16日耗資539萬港元回購114.6萬股

康臣藥業(01681.HK)9月16日耗資175.89萬港元回購50萬股

雷蛇(01337.HK)9月16日耗資158.52萬港元回購93.8萬股

中國水務(00855.HK)9月16日耗資145.67萬港元回購23.8萬股

【股權激勵】

丘鈦科技(01478.HK)授出1787.96萬份購股權

亞盛醫藥-B(06855.HK)向53名僱員授出233.3萬份受限制股份單位

債務融資】

中信證券(06030.HK)擬發行不超300億元次級公司債獲批

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account